CC-97540 (Zola-cel)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CC-97540 (Zola-cel), covering 2026-04-17 to 2026-04-17. Get the full timeline:
Most recent: Clinical Trial Update: A Study of CC-97540 (BMS-986353 or Zola-cel), CD19-Targeted NEX-T CAR T Cells, in Participants With Active SLE Despite Immunosuppressants (Breakfree-SLE) [Phase 2]